ROLANDO, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 3638
EU - Europa 2815
AS - Asia 1658
AF - Africa 116
SA - Sud America 70
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8356
Nazione #
US - Stati Uniti d'America 3506
IT - Italia 809
DE - Germania 685
CN - Cina 549
GB - Regno Unito 326
IN - India 292
KR - Corea 197
VN - Vietnam 137
JP - Giappone 116
CZ - Repubblica Ceca 114
FR - Francia 112
RU - Federazione Russa 105
CA - Canada 103
NL - Olanda 85
AT - Austria 78
ES - Italia 74
IR - Iran 60
IE - Irlanda 59
EG - Egitto 54
PL - Polonia 53
AU - Australia 49
UA - Ucraina 47
ID - Indonesia 45
TR - Turchia 44
DK - Danimarca 42
SE - Svezia 41
RO - Romania 39
HK - Hong Kong 34
BR - Brasile 32
TW - Taiwan 26
ZA - Sudafrica 24
MX - Messico 23
CH - Svizzera 20
SY - Repubblica araba siriana 19
TH - Thailandia 19
GR - Grecia 18
PK - Pakistan 17
FI - Finlandia 16
SG - Singapore 16
CO - Colombia 14
LT - Lituania 14
DZ - Algeria 13
HU - Ungheria 13
IQ - Iraq 11
PT - Portogallo 11
SA - Arabia Saudita 11
BE - Belgio 10
BG - Bulgaria 10
MY - Malesia 10
IL - Israele 9
NG - Nigeria 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
JO - Giordania 7
NZ - Nuova Zelanda 7
AR - Argentina 5
NO - Norvegia 5
BY - Bielorussia 4
CD - Congo 4
CY - Cipro 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AM - Armenia 3
BD - Bangladesh 3
EC - Ecuador 3
LV - Lettonia 3
MA - Marocco 3
MC - Monaco 3
QA - Qatar 3
RS - Serbia 3
AL - Albania 2
CU - Cuba 2
EU - Europa 2
LK - Sri Lanka 2
MK - Macedonia 2
PE - Perù 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
PS - Palestinian Territory 1
PY - Paraguay 1
SD - Sudan 1
SI - Slovenia 1
SN - Senegal 1
Totale 8354
Città #
Houston 371
Torino 334
Fairfield 313
Ann Arbor 207
Woodbridge 203
Ashburn 201
Buffalo 178
Beijing 166
Seattle 155
Santa Cruz 147
Wilmington 127
Cambridge 113
Dong Ket 95
Mountain View 87
University Park 81
Vienna 68
Wuhan 68
Seongnam 66
Turin 61
Dublin 54
Manchester 52
Hangzhou 42
Boardman 41
Chicago 41
Fleming Island 41
Atherstone 38
Bengaluru 32
Nürnberg 32
Council Bluffs 31
Nanjing 31
San Diego 31
Lake Forest 30
Madrid 30
Guangzhou 29
Toronto 28
Shanghai 26
Las Vegas 24
Copenhagen 23
Phoenix 23
Nottingham 21
Tokyo 21
London 20
Dallas 19
Ottawa 19
Taipei 19
Zhengzhou 19
Hanoi 18
Milan 18
New York 18
Seoul 18
Warsaw 18
Brooklyn 17
Delhi 17
Jakarta 17
Tappahannock 17
Athens 16
Hyderabad 16
Pisa 16
Stockholm 16
Catania 15
Clarks Summit 15
Shenyang 15
Gurgaon 14
Helsinki 14
Jinan 14
Los Angeles 14
Muizenberg 14
Siena 14
Carrara 13
Henderson 13
Pietra Ligure 13
Leawood 12
Moscow 12
Boulder 11
Brisbane 11
Hartford 11
Mumbai 11
Paris 11
San Jose 11
Zaragoza 11
Chengdu 10
Chennai 10
Dearborn 10
Riva 10
Rome 10
San Francisco 10
Alessandria 9
Berlin 9
Melbourne 9
Prague 9
Santa Maria Capua Vetere 9
Southend 9
Sydney 9
Atlanta 8
Bad Vilbel 8
Bedford 8
Birmingham 8
Changsha 8
Clearwater 8
Duncan 8
Totale 4528
Nome #
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition, file e27ce428-5e9e-2581-e053-d805fe0acbaa 575
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues, file e27ce426-cbfc-2581-e053-d805fe0acbaa 358
Multitarget Drugs: Focus on the NO-donor hybrid drugs, file e27ce426-b4e8-2581-e053-d805fe0acbaa 323
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs), file e27ce426-be80-2581-e053-d805fe0acbaa 309
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization, file e27ce426-cbf4-2581-e053-d805fe0acbaa 260
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs, file e27ce426-d83a-2581-e053-d805fe0acbaa 253
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria, file e27ce426-bdc3-2581-e053-d805fe0acbaa 250
New nitric oxide or hydrogen sulfide releasing aspirins, file e27ce426-d99c-2581-e053-d805fe0acbaa 245
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance., file e27ce426-e3dd-2581-e053-d805fe0acbaa 242
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile, file e27ce426-ead8-2581-e053-d805fe0acbaa 228
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization, file e27ce426-b8e0-2581-e053-d805fe0acbaa 222
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans, file e27ce426-dd5a-2581-e053-d805fe0acbaa 203
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells, file e27ce427-135c-2581-e053-d805fe0acbaa 203
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs, file e27ce426-f7b4-2581-e053-d805fe0acbaa 198
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light, file e27ce42d-b04b-2581-e053-d805fe0acbaa 198
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties, file e27ce426-aaa3-2581-e053-d805fe0acbaa 179
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, file e27ce426-ae93-2581-e053-d805fe0acbaa 171
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93b-2581-e053-d805fe0acbaa 144
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance., file e27ce426-e3df-2581-e053-d805fe0acbaa 139
Edaravone derivatives containing NO-donor functions, file e27ce426-bc77-2581-e053-d805fe0acbaa 135
1,2,5-Oxadiazole analogues of leflunomide and related compounds, file e27ce426-ca8a-2581-e053-d805fe0acbaa 124
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties, file e27ce426-ae92-2581-e053-d805fe0acbaa 111
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells, file e27ce42f-cff3-2581-e053-d805fe0acbaa 105
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents, file e27ce426-c650-2581-e053-d805fe0acbaa 103
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan, file e27ce42d-8dfe-2581-e053-d805fe0acbaa 98
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins, file e27ce428-7e0a-2581-e053-d805fe0acbaa 96
Preliminary ADME/PK studies of new hDHODH inhibitors effective for treatment of acute myeloid leukaemia (AML), file e27ce42f-16a0-2581-e053-d805fe0acbaa 95
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells, file e27ce426-f58a-2581-e053-d805fe0acbaa 94
Design and synthesis of SWIR emitters for optical imaging, file a3c77925-a20a-4f10-b791-18737969052f 93
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b275-2581-e053-d805fe0acbaa 90
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells, file e27ce42c-f044-2581-e053-d805fe0acbaa 84
Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters, file e27ce433-4d5c-2581-e053-d805fe0acbaa 83
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells., file e27ce42d-3004-2581-e053-d805fe0acbaa 79
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells, file e27ce427-03dc-2581-e053-d805fe0acbaa 76
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid, file e27ce426-bbb7-2581-e053-d805fe0acbaa 75
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni, file e27ce427-03db-2581-e053-d805fe0acbaa 74
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells, file e27ce430-524a-2581-e053-d805fe0acbaa 73
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties, file e27ce426-aaf2-2581-e053-d805fe0acbaa 72
New nitric oxide or hydrogen sulfide releasing aspirins, file e27ce426-d99d-2581-e053-d805fe0acbaa 72
Doxorubicin-antioxidant multitarget drugs, file e27ce426-f93a-2581-e053-d805fe0acbaa 70
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells, file e27ce431-6e5a-2581-e053-d805fe0acbaa 70
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-2d2f-2581-e053-d805fe0acbaa 64
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization, file e27ce426-b8e1-2581-e053-d805fe0acbaa 62
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-bf82-2581-e053-d805fe0acbaa 61
Ketogal safety profile in human primary colonic epithelial cells and in mice, file e27ce434-10e8-2581-e053-d805fe0acbaa 60
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light, file e27ce42c-1578-2581-e053-d805fe0acbaa 59
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity, file e27ce426-b440-2581-e053-d805fe0acbaa 57
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor, file e27ce42c-bcef-2581-e053-d805fe0acbaa 56
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine, file e27ce431-2421-2581-e053-d805fe0acbaa 56
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization, file e27ce426-bbd1-2581-e053-d805fe0acbaa 55
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors., file e27ce427-b2ad-2581-e053-d805fe0acbaa 51
Edaravone derivatives containing NO-donor functions, file e27ce426-bc79-2581-e053-d805fe0acbaa 50
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity, file e27ce426-c49d-2581-e053-d805fe0acbaa 50
New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold, file e27ce435-3b91-2581-e053-d805fe0acbaa 50
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells, file e27ce42e-70b1-2581-e053-d805fe0acbaa 49
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3, file e27ce432-dedb-2581-e053-d805fe0acbaa 49
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors, file e27ce433-402c-2581-e053-d805fe0acbaa 49
Quinone based nitric oxide donating compounds, file e27ce427-a390-2581-e053-d805fe0acbaa 48
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance, file e27ce428-be10-2581-e053-d805fe0acbaa 48
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce432-dd86-2581-e053-d805fe0acbaa 40
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells, file e27ce433-4651-2581-e053-d805fe0acbaa 37
Multitarget Drugs: No-Donor Doxorubicins, file e27ce427-664a-2581-e053-d805fe0acbaa 36
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-615d-2581-e053-d805fe0acbaa 36
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study, file e27ce434-a776-2581-e053-d805fe0acbaa 36
Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies, file e27ce433-0b18-2581-e053-d805fe0acbaa 35
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts, file e27ce42e-af48-2581-e053-d805fe0acbaa 34
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents, file e27ce426-df67-2581-e053-d805fe0acbaa 33
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands, file e27ce42d-8df5-2581-e053-d805fe0acbaa 32
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production, file e27ce42b-e9f3-2581-e053-d805fe0acbaa 31
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization, file e27ce426-cbf5-2581-e053-d805fe0acbaa 29
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug, file e27ce435-98a8-2581-e053-d805fe0acbaa 29
New furoxan derivatives for the treatment of ocular hypertension, file e27ce42b-15a7-2581-e053-d805fe0acbaa 28
4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site, file e27ce433-34f7-2581-e053-d805fe0acbaa 27
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension, file e27ce42c-8ff0-2581-e053-d805fe0acbaa 25
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery, file e27ce42c-8ff2-2581-e053-d805fe0acbaa 25
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae, file e27ce432-ebba-2581-e053-d805fe0acbaa 24
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-3a6a-2581-e053-d805fe0acbaa 23
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance, file e27ce42b-59af-2581-e053-d805fe0acbaa 23
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce433-469a-2581-e053-d805fe0acbaa 22
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity, file e27ce426-c49c-2581-e053-d805fe0acbaa 21
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE, file e27ce429-dd38-2581-e053-d805fe0acbaa 20
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce42c-ef0f-2581-e053-d805fe0acbaa 20
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY., file e27ce42f-0382-2581-e053-d805fe0acbaa 19
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety, file 33b0c0fc-4948-4f36-822a-38bf37292599 18
Multitarget Drugs: No-Donor Doxorubicins, file e27ce427-664b-2581-e053-d805fe0acbaa 18
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bb56-2581-e053-d805fe0acbaa 17
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins, file e27ce426-b276-2581-e053-d805fe0acbaa 16
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease, file e27ce427-2d32-2581-e053-d805fe0acbaa 15
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma, file e27ce42e-1c89-2581-e053-d805fe0acbaa 15
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells, file e27ce431-9d9c-2581-e053-d805fe0acbaa 14
A generator of peroxynitrite activatable with red light, file e27ce432-66d7-2581-e053-d805fe0acbaa 14
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER, file e27ce42e-7875-2581-e053-d805fe0acbaa 13
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs, file e27ce426-d83b-2581-e053-d805fe0acbaa 12
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells, file e27ce42e-114b-2581-e053-d805fe0acbaa 12
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae, file e27ce42e-af49-2581-e053-d805fe0acbaa 12
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug, file e27ce42e-df97-2581-e053-d805fe0acbaa 12
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-fd74-2581-e053-d805fe0acbaa 12
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein, file d8cded6f-e57e-4e8c-87da-877e19c5510e 7
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins, file e27ce428-7f7e-2581-e053-d805fe0acbaa 7
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors, file e27ce42c-a984-2581-e053-d805fe0acbaa 7
Totale 8552
Categoria #
all - tutte 12011
article - articoli 0
book - libri 0
conference - conferenze 545
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201838 0000 00 00 00038
2018/2019870 47642960 4639 5577 64118145126
2019/20201374 12481116228 11879 103101 12410195104
2020/20211201 721318784 10694 9492 82116107136
2021/20221626 12290119291 19595 10297 8176238120
2022/20231763 63102222184 168158 221177 1781601300
Totale 8734